ReCerise Therapeutics Inc. ("ReCerise"), a company committed to research and development of first-in-class therapeutics in ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Vision changes are an inevitable part of aging, but why are some more susceptible to age-related eye diseases and why do some ...

Extraordinary funding from the Chan Zuckerberg Initiative supports two large collaborative projects that will boost imaging technology development ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...